Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model
Experimental Dermatology · 2024
DOI: 10.1111/exd.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Meijuan Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Jichi Medical University, Tochigi, Japan. Hauptthemen laut MEDLINE: Interleukin-33, Reperfusion Injury, Pressure Ulcer, Mice, Knockout. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: LSRFortessa was subsidized by the JKA through its promotion funds from KEIRIN RACE, JSPS Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Research Activity Start-up.
Themen: Dekubitus
Abstract (Originalsprache)
Interleukin‐33 (IL‐33) is an alarmin released upon epithelial tissue damage. It functions as a nuclear factor for regulating gene expression. We hypothesised that IL‐33 is involved in the formation of decubitus ulcers through damaged epidermis. Therefore, this study aimed to clarify the mechanism of IL‐33 action in decubitus ulcer formation. IL‐33 knockout (KO), soluble stimulation‐2 (ST2) transgenic, and wild‐type (WT) mice were used to construct an ischemia–reperfusion (I/R) injury as a decubitus model. The ulcer area was significantly reduced in IL‐33 KO mice compared to WT mice but was not reduced in ST2 transgenic mice. Anti‐IL‐33 receptor (transmembrane ST2) antibodies effectively prevented ulcer formation; however, an anti‐IL‐33 neutralising antibody was ineffective. The number of infiltrating macrophages was higher, while that of neutrophils and mast cells was lower in IL‐33 KO mice than in WT mice. The number of M2 macrophages increased in IL‐33 KO mice. Characterisation of gene expression levels revealed significantly reduced interleukin‐1 beta (IL‐1β) and increased C‐C motif chemokine ligand 17 expression in IL‐33 KO mice. Macrophages isolated from ulcers in WT or IL‐33 KO mice stimulated with exogenous IL‐33 produced comparable amounts of IL‐1β. In conclusion, our study indicates that IL‐33 is released in response to I/R injury in the skin, contributing to inflammatory macrophage and mast cell infiltration and stimulation, resulting in IL‐1β production and the massive infiltration of effector cells, including neutrophils, which finally induces decubitus ulcer formation. These results suggest that suppressing IL‐33 expression could be beneficial for treating early‐phase decubitus ulcers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Jichi Medical University, Tochigi, Japan.
- Department of Biochemistry, Jichi Medical University, Tochigi, Japan.
- Division of Human Genetics, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
- Graduate School of Integrated Science of Life, Hiroshima University Graduate School, Hiroshima, Japan.
- Department of Dermatology, Gunma University, Maebashi, Gunma, Japan.
ORCID-Profile: Mayumi Komine, Hidetoshi Tsuda, Sei-Ichiro Motegi
Förderung
- LSRFortessa was subsidized by the JKA through its promotion funds from KEIRIN RACE
- JSPS Grant-in-Aid for Scientific Research (C)
- Grant-in-Aid for Research Activity Start-up
Zitieren
APA
Jin, M., Komine, M., Tsuda, H., Sashikawa-Kimura, M., Nakae, S., Motegi, S. I., & Ohtsuki, M. (2024). Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model. Experimental Dermatology. https://doi.org/10.1111/exd.70014
Vancouver
Jin M, Komine M, Tsuda H, Sashikawa-Kimura M, Nakae S, Motegi SI, et al. Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model. Experimental Dermatology. 2024. doi:10.1111/exd.70014
BibTeX
@article{Jin2024,
author = {Jin, Meijuan and Komine, Mayumi and Tsuda, Hidetoshi and Sashikawa-Kimura, Miho and Nakae, Susumu and Motegi, Sei-Ichiro and Ohtsuki, Mamitaro},
title = {Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.70014}
}
EUVIMED